Johnson & Johnson
-
Trends
Johnson & Johnson sells its most extensive India plans as demand weakens.
Johnson & Johnson sells its most extensive India plans as demand weakens. The company’s manufacturing plant was built on 55.27…
Read More » -
Trends
Johnson & Johnson baby powder is banned globally but will not discontinue in India; the Indian Drug regulatory authority is silent.
Johnson & Johnson baby powder is banned globally but will not discontinue in India; the Indian Drug regulatory authority is…
Read More » -
Stories
The FDA Shows Green Light To Johnson & Johnson As It Becomes The 3rd Vaccine To Get Emergency Use Approval
The FDA Shows Green Light To Johnson & Johnson As It Becomes The 3rd Vaccine To Get Emergency Use Approval…
Read More » -
Stories
UK to run final stage trials of Janssen Covid vaccine
Britain will be the first country to run final stage trials of an experimental coronavirus vaccine being developed by the…
Read More » -
Trends
By December, India May Have 100 Million Doses Of COVID-19 Vaccine: World’s Greatest Hope For Effective Coronavirus Vaccine Comes From India! Here’s A Status Check Of The COVID-19 Vaccine Frontrunners
The world’s largest vaccine manufacturer, Serum Institute of India, is increasing the production of AstraZeneca’s coronavirus injections. Its goal is…
Read More » -
Stories
Vaccine Trial at Standstill: Johnson & Johnson Halts Clinical Study as Participants Fall Sick Due to Unexplained Illness
Johnson & Johnson has temporarily halted its COVID-19 vaccine trial because one of its participants had become sick. In a…
Read More » -
Trends
Amid Ongoing Debate over the Mental Illness, Johnson & Johnson’s Nasal Spray ‘SPRAVATO’ get approval as an antidepressant drug for “People With Suicidal Thoughts”
Social isolation, fear of contamination, anxiety, uncertainty, chronic strain, and financial difficulties may lead to the development or exacerbation of…
Read More » -
Trends
Workforce training app developer Poka adds strategic investor Schneider Electric
Poka, a workforce training app and software service for industrial companies, has added SE Ventures, the venture capital arm of…
Read More » -
Business
Johnson & Johnson can make vaccines by next year, Will invest 7.5 thousand crore. Team which prepared SARS vaccine is involved in it
Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency…
Read More »